
Liraglutide injection
Form: Pre filled Pen
Strength: 6 mg/mL
Reference Brands: Saxenda®(US & EU)
Category: Diabetes
Saxenda® (liraglutide 3 mg), a GLP-1 receptor agonist, is FDA-approved for chronic weight management in adults (BMI ≥30 or ≥27 with comorbidities) and adolescents (12+). The EMA approves it for adults only, with similar BMI criteria. Both regulators mandate a boxed warning for thyroid C-cell tumor risk and contraindicate use in patients with personal/family history of MTC or MEN 2. Discontinue if <5% weight loss occurs after 12 weeks. Storage: Refrigerate (2–8°C); stable at ≤30°C (USA) or ≤25°C (EU) post-opening. Platforms like Pharmatradz.com streamline global B2B access to compliant Saxenda® sourcing and licensing.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Premixed Insulins (70/30, 50/50) Injectable
Strength: U-100
Form: Vials, pens
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
View Details Get EnquiryInsulin Lispro (Humalog) injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)
View Details Get EnquiryInsulin Aspart (Novolog) injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Novolog, Fiasp(US &EU)
View Details Get EnquiryInsulin Glargine (Lantus) injectable
Strength: U-100, U-300
Form: Vials/pens
Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)
View Details Get Enquiry